60 Degrees Pharmaceuticals (SXTP) EBIT (QoQ) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) EBIT (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.26% |
| Dec 31, 2025 | 17.55% |
| Sep 30, 2025 | -44.91% |
| Jun 30, 2025 | 16.02% |
| Mar 31, 2025 | 7.47% |
| Dec 31, 2024 | 2.52% |
| Sep 30, 2024 | 49.42% |
| Jun 30, 2024 | -212.02% |
| Mar 31, 2024 | 29.13% |
| Dec 31, 2023 | -24.47% |
| Sep 30, 2023 | -93.12% |
| Jun 30, 2023 | 17.11% |
| Mar 31, 2023 | -38.84% |
| Dec 31, 2022 | -218.29% |
| Sep 30, 2022 | 68.68% |